KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EBT (2016 - 2026)

Zimmer Biomet Holdings has reported EBT over the past 18 years, most recently at $301.3 million for Q1 2026.

  • For Q1 2026, EBT rose 31.57% year-over-year to $301.3 million; the TTM value through Mar 2026 reached $1.0 billion, up 29.03%, while the annual FY2025 figure was $958.3 million, 22.11% up from the prior year.
  • EBT for Q1 2026 was $301.3 million at Zimmer Biomet Holdings, up from $225.5 million in the prior quarter.
  • Over five years, EBT peaked at $302.2 million in Q2 2024 and troughed at $37.2 million in Q4 2024.
  • A 5-year average of $221.0 million and a median of $225.5 million in 2025 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 86.92% in 2024 and later soared 506.18% in 2025.
  • Year by year, EBT stood at $167.6 million in 2022, then skyrocketed by 69.75% to $284.5 million in 2023, then crashed by 86.92% to $37.2 million in 2024, then soared by 506.18% to $225.5 million in 2025, then skyrocketed by 33.61% to $301.3 million in 2026.
  • Business Quant data shows EBT for ZBH at $301.3 million in Q1 2026, $225.5 million in Q4 2025, and $279.2 million in Q3 2025.